COMPANY
DT MedTech
DT MedTech is listed on ClinicalTrials.gov as the lead sponsor of 2 studies; the most recently updated is “Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System” (no phase, active not recruiting), in Osteoarthritis Ankle, Post-Traumatic Osteoarthritis of Ankle, Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder). From public records Source · Oct 12, 2026